Evidence map›Paper›PMID 11574690›Full record

ArticleNucleic acids research2001

Activation of the human PAX6 gene through the exon 1 enhancer by transcription factors SEF and Sp1.

J B Zheng, Y H Zhou, T Maity, W S Liao, G F Saunders

Open access · bronzeAbstract read
In one paragraph

Article in Nucleic acids research, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. PAX6 MiniPromoters drive restricted expression from rAAV in the adult mouse retina.Molecular therapy. Methods & clinical development · 2016
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Identification of genes conferring resistance to 5-fluorouracil.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

J B ZhengDepartment of Biochemistry, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
Y H Zhou
T Maity
W S Liao
G F Saunders
The University of Texas MD Anderson Cancer Center · US

Funding

VISION RESEARCHP30EY010608 · NEI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MASSEY, STEPHEN C · 1994 to 2014
$7.9M
PAX6 FUNCTION AND ANIRIDIAR01EY009675 · NEI · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI SAUNDERS, GRADY F · 1992 to 2004
$1.5M
PAX6 TARGET GENES AND EYE DEVELOPMENTF32EY006949 · NEI · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI ZHOU, YI-HONG · 1998 to 1999
–
NEI NIH HHS 5F32 EY06949-02NEI NIH HHS EY09675NEI NIH HHS EY10608NEI NIH HHS F32 EY006949NEI NIH HHS P30 EY010608NEI NIH HHS R01 EY009675
6 · The paper itself

Abstract

PAX6 is a transcription factor that plays a major role in ocular morphogenesis. PAX6 is expressed in the eye, central nervous system and pancreas. Two alternative promoters, P0 and P1, which are differentially regulated during development, drive PAX6 transcription. We identified a 57 bp cis-regulatory element in exon 1 of the human PAX6 gene exon 1 enhancer (EIE). EIE enhances P1-driven PAX6 expression. Three regions in E1E (E1E-1, E1E-2 and E1E-3) have sequence similarities with binding sites of transcription factors ARP-1, Isl-1 and SEF, respectively. As shown by electrophoretic mobility shift assays, E1E-3, but not E1E-1 or E1E-2, bound to proteins in nuclear extracts of human glioma cells and transcription factor SEF bound to E1E-3. As shown by transient transfection experiments, deletion or site-specific mutations in E1E-3 dramatically decreased P1 promoter activity. Mutations in E1E-2, however, did not affect function of the P1 promoter. Co-transfection of SEF and PAX6 promoter-reporter constructs showed that SEF up-regulates PAX6 gene expression through the P1 promoter. Two Sp1 sites in the E1E region were also shown to be important by transient co-transfection assays. Data from immunoprecipitation and transient transfection assays demonstrated that SEF and Sp1 interacted in vitro and may act together in vivo to regulate PAX6 expression.

Indexed as

Enhancer Elements, GeneticBase SequenceBinding SitesCell ExtractsCell NucleusDNA-Binding ProteinsExonsEye ProteinsGenes, ReporterHomeodomain ProteinsHumansMolecular Sequence DataMutagenesis, Site-DirectedPaired Box Transcription FactorsPAX6 Transcription FactorPromoter Regions, GeneticCell ExtractsDNA-Binding ProteinsEye ProteinsHomeodomain ProteinsPaired Box Transcription FactorsPAX6 protein, humanPAX6 Transcription FactorRepressor ProteinsRNA-Binding ProteinsSp1 Transcription FactorTranscription Factors

Identifiers

PMID11574690
PMCPMC60230
OpenAlexW2102380798

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.